Celuarity is a commercial stage cellular therapeutic company focusing on allogenic cellular therapies. Celularity is headquartered in Warren, New Jersey and was founded in 2016 by Carlos Ramirez, Jerome Zeldis, Jodi Gurney, John R Haines, Robert Hariri, and Steven French.
On September 28, 2017 Celularity announced closing a venture round raising $40 million in capital from undisclosed investors.
On February 15, 2018 Celularity completed their second round of venture funding with $250 million in capital from Colgene (lead investor), United Therapeutics, Sorrento Therapeutics, Section 32, Human Longetivity, Celgene, Bill Maris, and Tony Robbins.
Timeline
On February 15, 2018 Celularity completed their second round of venture funding with $250 million in capital from Colgene (lead investor), United Therapeutics, Sorrento Therapeutics, Section 32, Human Longetivity, Celgene, Bill Maris, and Tony Robbins.
On September 28, 2017 Celularity announced closing a venture round raising $40 million in capital from undisclosed investors.
Celularity is headquartered in Warren, New Jersey and was founded in 2016 by Carlos Ramirez, Jerome Zeldis, Jodi Gurney, John R Haines, Robert Hariri, and Steven French.
Funding rounds
People
Further reading
Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration
Celularity
Web
Documentaries, videos and podcasts
Companies
News
References
Company attributes
Categories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 3
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 4
Henry Ogolla
Passionate about reading and writing.